Robert A. Beardsley

2019

In 2019, Robert A. Beardsley earned a total compensation of $1.7M as Chief Operating Officer at Galera Therapeutics, a 294% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$97,551
Option Awards$1,212,186
Salary$358,476
Total$1,668,213

Beardsley received $1.2M in option awards, accounting for 73% of the total pay in 2019.

Beardsley also received $97.6K in non-equity incentive plan and $358.5K in salary.

Rankings

In 2019, Robert A. Beardsley's compensation ranked 6,800th out of 13,971 executives tracked by ExecPay. In other words, Beardsley earned more than 51.3% of executives.

ClassificationRankingPercentile
All
6,800
out of 13,971
51st
Division
Manufacturing
2,596
out of 5,701
55th
Major group
Chemicals And Allied Products
952
out of 2,200
57th
Industry group
Drugs
804
out of 1,886
57th
Industry
Pharmaceutical Preparations
589
out of 1,398
58th
Source: SEC filing on April 27, 2020.

Beardsley's colleagues

We found two more compensation records of executives who worked with Robert A. Beardsley at Galera Therapeutics in 2019.

2019

J Sorensen

Galera Therapeutics

Chief Executive Officer

2019

Christopher Degnan

Galera Therapeutics

Chief Financial Officer

News

In-depth

You may also like